Apteki - Anna Kalisorassp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-31
Share capital
50,000.00 PLN
Registered address
Dworcowa 2 B, 64-125 Poniec, Poland
Electronic delivery address
AE:PL-37438-40203-GFBTT-28

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 79 days early.

  • 202528/04/2026
  • 202406/05/2025
  • 202324/06/2024
  • 202205/04/2023
  • 202131/05/2022
  • 202011/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 9.38mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 415.53kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 8.86mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.56mMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteki - Anna Kalisoras has been an NFZ healthcare provider since 2024. In 2026 it is performing 4 contracts with a total value of USD 45.52k. All its contracts were worth USD 123.09k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmacieswielkopolskie2USD 44.44k
Pilot programmeswielkopolskie2USD 1.08k

Authorized Representatives

Justyna Kalisoras – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Anna Maria Kalisorasage 80
15$4,051.8630%
Justyna Kalisorasage 55
35$9,454.3570%

Justyna Kalisoras and Anna Maria Kalisoras hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-12-17.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$249.8K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.
Farmjugsp. z o.o.
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Rutkiewicz I Wspólnicysp. j.

FAQ

Last updated: 2026-04-28